ID

4471

Description

A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer Inclusion Criteria: - Diagnosis of prostate cancer. - Rising PSA while on hormonal therapy or following surgical castration. - Documented evidence of metastatic disease. Exclusion Criteria: - Have received cytotoxic chemotherapy. - Have received opioid or narcotic medications (such as codeine or morphine) or radiation for pain caused by your prostate cancer in the last 6 months

Mots-clés

Versions (1)
  1. 09/12/2013 09/12/2013 - Martin Dugas
Téléchargé le

9 décembre 2013

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0 Legacy
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility DRKS00009647 NCT00036543 Prostate Cancer

Allemand Anglais

Eligibility

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion criteria
Description

Inclusion criteria

Diagnosis of prostate cancer
Description

Diagnosis

Type de données

boolean

Rising PSA while on hormonal therapy or following surgical castration
Description

PSA

Type de données

boolean

Documented evidence of metastatic disease
Description

Metastasis

Type de données

boolean

Exclusion criteria
Description

Exclusion criteria

Have received cytotoxic chemotherapy
Description

Chemotherapy

Type de données

boolean

Have received opioid or narcotic medications (such as codeine or morphine) or radiation for pain caused by your prostate cancer in the last 6 months
Description

Pain by Prostate Cancer

Type de données

boolean

Medical Concepts
Description

Medical Concepts

Diagnosis
Description

Diagnosis

Type de données

string

Alias
UMLS CUI
C0011900
SNOMED CT 2010_0731
439401001
PSA
Description

Prostate-Specific Antigen

Type de données

string

Alias
UMLS CUI
C0138741
SNOMED CT 2010_0731
102687007
Metastatic malignant disease
Description

Secondary malignant neoplastic disease

Type de données

string

Alias
UMLS CUI
C0027627
SNOMED CT 2010_0731
128462008
Cancer chemotherapy
Description

Chemotherapy

Type de données

string

Alias
UMLS CUI
C0392920
SNOMED CT 2010_0731
150415003
Medication
Description

Pharmaceutical Preparations

Type de données

string

Alias
UMLS CUI
C0013227
Radiotherapy
Description

Radiotherapy

Type de données

string

Alias
UMLS CUI
C1522449
SNOMED CT 2010_0731
302505005
Retour au début de la page

Similar models

Eligibility

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion criteria
Diagnosis
Item
Diagnosis of prostate cancer
boolean
PSA
Item
Rising PSA while on hormonal therapy or following surgical castration
boolean
Metastasis
Item
Documented evidence of metastatic disease
boolean
Item Group
Exclusion criteria
Chemotherapy
Item
Have received cytotoxic chemotherapy
boolean
Pain by Prostate Cancer
Item
Have received opioid or narcotic medications (such as codeine or morphine) or radiation for pain caused by your prostate cancer in the last 6 months
boolean
Item Group
Medical Concepts
Diagnosis
Item
Diagnosis
string
C0011900 (UMLS CUI)
439401001 (SNOMED CT 2010_0731)
Prostate-Specific Antigen
Item
PSA
string
C0138741 (UMLS CUI)
102687007 (SNOMED CT 2010_0731)
Secondary malignant neoplastic disease
Item
Metastatic malignant disease
string
C0027627 (UMLS CUI)
128462008 (SNOMED CT 2010_0731)
Chemotherapy
Item
Cancer chemotherapy
string
C0392920 (UMLS CUI)
150415003 (SNOMED CT 2010_0731)
Pharmaceutical Preparations
Item
Medication
string
C0013227 (UMLS CUI)
Radiotherapy
Item
Radiotherapy
string
C1522449 (UMLS CUI)
302505005 (SNOMED CT 2010_0731)
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial